US3732229A - 3-cyclohexyl phenyl-2-hydroxypropyl-4-phenyl piperazines - Google Patents

3-cyclohexyl phenyl-2-hydroxypropyl-4-phenyl piperazines Download PDF

Info

Publication number
US3732229A
US3732229A US00156092A US3732229DA US3732229A US 3732229 A US3732229 A US 3732229A US 00156092 A US00156092 A US 00156092A US 3732229D A US3732229D A US 3732229DA US 3732229 A US3732229 A US 3732229A
Authority
US
United States
Prior art keywords
ethanol
piperazine
mixture
solution
hydroxypropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00156092A
Inventor
P Bysouth
R Clarke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BDH Chemicals Ltd
Original Assignee
BDH Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BDH Chemicals Ltd filed Critical BDH Chemicals Ltd
Application granted granted Critical
Publication of US3732229A publication Critical patent/US3732229A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/12Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the ring of aromatic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Definitions

  • R is alkyl having up to 10 carbon atoms, alkoxy having up to 10 carbon atoms, cycloalkyl having from 5 to 7 carbon atoms, cycloalkyloxy having from 5 to 7 carbon atoms, cycloalk-l-enyl having from 5 to 7 carbon atoms, phenyl, phenoxy or halogen;
  • R is hydrogen or methyl
  • R is Z-hydroxycyclohexyl, 2-pyridyl, phenyl, dimethoxyphenyl, chloronitrophenyl, chloromethoxyphenyl, and methyldisulphamoylphenyl, phenyl substituted with a group selected from those consisting of alkyl having up to 4 carbon atoms, alkoxy having from 1 to 4 carbon atoms, fluorine, chlorine, bromine, nitro, amino, sulphamoyl, hydroxy, trifluoromethyl and acetamido; and
  • the compounds of the present invention are effective as central nervous system depressants.
  • the compound 1-[3-(p-cyclohexylphenyl)-2-hydroxypropyl] 4 o-methoxyphenylpiperazine dihydrochloride, the product of Example 8, is a central nervous system depressant. Thus it was twice as active as morphine in the mouse tail-pinch test, three times as active as chlorpromazine in the mouse rage test and twice as active as chlorpromazine in the anti-amphetamine test.
  • EXAMPLE 1 A X CPZ in mouse rage test. /2 CPZ in antiamphetamine test.
  • EXAMPLE 3 2X CPZ in mouse rage test. 4 CPZ in reducing spontaneous motor activity.
  • EXAMPLE 22 Equals CPZ in mouse rage test. /2 x CPZ in reduction of spontaneous motor activity.
  • EXAMPLE 24 73 CPZ in mouse rage test. 1A CPZ in reduction of spontaneous motor activity.
  • CPZ above denotes chlorpromazine.
  • R alkyl, either straight or branched chain containing up to 10 carbon atoms; alkoxy, either straight or branched chain up to 10 carbon atoms; cycloalkyl containing from 5-7 carbon atoms; cycloalkyloxy containing from 5-7 carbon atoms; cycloalk-l-enyl (e.g.
  • cyclohex-lenyl containing from 5-7 carbon atoms
  • R hydrogen or methyl
  • R 2-hydroxycyclohexyl
  • phenyl or mono-, dior trisubstituted phenyl such substituents include alkyl, containing up to 4 carbon atoms; alkoxy, containing from 1-4 carbon atoms; fluorine; chlorine; bromine; nitro; amino; acylamino; tn'fiuoromethyl; sulphamoyl and hydroxy).
  • group R may represent a 2-pyridy1 nucleus.
  • the compounds of the present invention may be used as the free bases or in the form of their salts with inorganic or organic acids, which in general will be pharmaceutically acceptable in their own right, such for example as hydrochloric, sulphuric, phosphoric, benzoic, citric, maleic, tartaric or salicylic acids.
  • a process for the preparation of piperazine derivatives having the general Formula I above which process comprises reacting a chlorohydrin having the formula @wmbwmomcr B1 (where R, and R and R have the same meaning as above) and a base and a substituted piperazine having the formula HN N-R (III) (where R has the same meaning as above)
  • the base is an inorganic base such as potassium hydroxide or sodium carbonate or an organic base in the form of an excess of the substituted piperazine. In the latter case the reaction .may be carried out employing 2 mole equivalents of the substituted piperazine.
  • potassium hydroxide employed as the inorganic base the reaction proceeds as shown below:
  • R, R, R and R have the same significance as in Formula I.
  • the chlorohydrin (II) may be treated with cold methanolic potassium hydroxide or heated with aqueous
  • solvents such as, for example, alcohols, hydrocarbons, ethers or aqueous alcohols. Reaction temperatures are not critical, but in most cases it was found satisfactory to heat the reactants in ethanol or .methanol at reflux temperature for several hours.
  • the products may be purified by distillation at reduced pressure or by crystallisation from an appropriate solvent. In some cases it was found most convenient to convert the basic product into a suitable salt which could then be purified by crystallisation.
  • Chlorohydrins of Formula II employed as starting materials in the present invention are described in our British specification No. 1,040,735 together with their preparation.
  • EXAMPLE 1 1-[3-(p-cyclohexylphenyl)-2-hydroxypropyl]-4-o-tolylpiperazine hydrochloride A solution of 1-chloro-3-(p-cyclohexylphenyl)propan 2-01 (10.1 g.) in methanol (50 ml.) was treated with a solution of potassium hydroxide (11.2 g.) in methanol ml.) followed by l-o-tolylpiperazine dihydrochloride (10 g.). The mixture was heated under reflux for 2 hours and excess of methanol was boiled off and the residue diluted with water.
  • the resultant oil was isolated with chloroform, the chloroform extracts were washed with water and the solvent distilled off, last traces being removed at reduced pressure (25 mm.). The residual oil was dissolved in isopropanol (80 ml.) and treated with a slight excess of hydrogen chloride. The solution was diluted with ether and cooled to 5 C. overnight. The product (9.8 g.) was collected and crystallised from water containing a small amount of ethanol. It had M.P. 23 3235 C.
  • EXAMPLE 2 1- [3 (p-eyclohexylphenyl -2-hydroxypropyl] -4-m-tolylpiperazine hydrochloride A solution of l-chloro-3-(p-cyclohexylphenyl)propan- 2-01 (10.1 g.) in ethanol (50 ml.) was treated with a solution of 85% potassium hydroxide (10.5 g.) in methanol (60 ml.) followed by a solution of l-(m-tolyl) piperazine dihydrochloride hydrate (10.7 g.) in ethanol (50 ml.) and the mixture was heated under reflux for 10 hours.
  • EXAMPLE 8 1- 3- (p-cyclohexylphenyl -2-hydroxypropyl] -4-omethoxyphenylpiperazine dihydrochloride
  • a solution of 1-chloro-3-(p-cyclohexylphenyl)propan- 2-01 (8.8 g.) in ethanol (100 ml.) was treated with a solution of 85% potassium hydroxide (7.25 g.) in methanol (70 ml.) followed by l-(o-methoxyphenyl)-piperazine dihydrochloride (9.3 g.) and the mixture was heated under reflux for 5 hours.
  • the precipitated potassium chloride was filtered off and the ethanol was distilled off, last traces being removed at reduced pressure.
  • EXAMPLE 10 1- 3- (p-biphenylyl -2-hydroxypropyl] -4-o-chlorophenylpiperazine hydrochloride a) 3-(p-biphenylyl) 1,2 epoxypropane.A suspension of l-(p-biphenylyl)-3-chloropropan-2-ol (49.3 g.) in water (1 litre) and ethanol (250 ml.) containing sodium carbonate (42.4 g.) was heated with efficient stirring for 4 hours with free evaporation of the ethanol. The resultant oil was isolated with chloroform to yield the epoxide (37.2 g.) B.P. 130132 C. at 0.35 mm., M.P. 51 C. (from methanol).
  • EXAMPLE 15 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl -4- (p-methoxyphenyl) -piperazine dihydrochloride This compound was prepared in the same way as the m-methoxyphenyl analogue described in Example 14 except that l-(p-methoxyphenyl)-piperazine dihydrochloride was used in place of 1-(m-methoxyphenyl)-piperazine dihydrochloride.
  • the dihydrochloride g.) had M.P. 195- 197 C. after crystallisation from the mixture of ethanol and ether.
  • EXAMPLE 16 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- phenylpiperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohexyl)phenylpropan- 2-01 (10.1 g.) in ethanol (150 ml.) was treated with 1- phenylpiperazine (6.5 g.) followed by a solution of 85% potassium hydroxide (2.8 g.) in methanol (25 ml.) and the mixture was refluxed for 12 hours. The base was isolated with chloroform and converted into a dihydrochloride as described in earlier examples. The product (5 g.) had M.P. 103105 C. after crystallisation from methanol.
  • the precipitated potassium chloride was filtered off, the filtrate concentrated to remove ethanol, and the basic residue partitioned between chloroform and water.
  • the chloroform extract was concentrated, the residual oil was dissolved in an equal volume of ethanol and treated with a slight excess of hydrogen chloride. Dilution with ether yielded the hydrochloride (8.4 g.) which had M.P. 181- 183 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 20 1(m-bromophenyl)-4-[3-(p-cyclohexy1phenyl) -2- hydroxypropyl]piperazine hydrochloride
  • (a) 1-(m-bromophenyl)piperazine hydrochloride.
  • a mixture of rn-bromoaniline (68.8 g.) and bis-(2-chloroethyl) amine hydrochloride (71.4 g.) in ethanol (250 ml.) was heated at reflux temperature for 10 hours when anhydrous sodium carbonate (21.2 g.) was added to the mixture and heating was continued for a further 10 hours.
  • the mixture was filtered hot, concentrated to half-bulk and cooled when the product separated. It (22.7 g.) had M.P. 2172l9 C. after crystallisation from ethanol.
  • EXAMPLE 21 1- [3 (p-cyclohexylphenyl -2-hydroxypropyl -4- (onitrophenyl) piperazine hydrochloride This compound (12.8 g.) was obtained by reaction of 1-chloro-3-p-cyclohexylphenylpropan-Z-ol (10.1 g.) with l-o-nitrophenylpiperazine (8.3 g.) in ethanol (70 ml.) containing potassium hydroxide at reflux temperature for 8 hours. The crude base was isolated and converted into the hydrochloride which had M.P. 180182 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 22 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- (2- pyridyl) piperazine hydrochloride This compound was prepared in 66% yield by reaction of 1-chloro-3-pcyclohexylphenylpropan-Z-ol with 1-(2'- pyridyl) piperazine in ethanol in the presence of potassium hydroxide followed by conversion of the base into the hydrochloride as described in earlier Examples.
  • the hydrochloride had M.P. 223224 C. after crystallisation from isopropanol.
  • EXAMPLE 23 1-[3-p-(cyclohexylphenyl)-2-hydroxy-2-methylpropy1]- 4-o-methoxy-phenylpiperazine hydrochloride (a) 1-chloro-3-(p-cyclohexylphenyl) 2 methylpropan-2-ol.--To a Grignard solution prepared from magnesium (4.8 g.) and p-bromophenylcyclohexane (48 g.) in ether (250 ml.), fl-methylepichlorohydrin (44.4 g.) was added dropwise with stirring during 1 hour and stirring was continued for a further 2 hours.
  • EXAMPLE 24 1- [3 (p-cyclohexyloxyphenyl) -2-hydroxypropyl] -4- omethoxyphenyl) piperazine hydrochloride (a) 1-chloro-3-(p-cyclohexyloxyphenyl)propan-Z-oL- A Grignard solution was prepared from p-bromophenoxycyclohexane (92.9 g.) and magnesium (13.2 g.) in ether 400 ml. This solution was stirred and treated with epichlorohydrin (102 g.) added at such a rate that the reaction was maintained at gentle reflux temperature.
  • EXAMPLE 25 1- [3 p-cyclohexylphenyl -2-hydroxypropyl] -4- (ofiuorophenyl) piperazine hydrochloride This compound was prepared by reaction of l-chloro- 3-(p-cyclohexylphenyl)-propan-2-ol with 1-(0 fluorophenyl)piperazine using the experimental procedure described in Example 3. It was obtained in 47% yield and had M.P. 192.5-193.5 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 30 1- (m-chlorophenyl) -4- [3 (p-cyclohexylphenyl) -2-hydroxypropyl]-piperazine hydrochloride
  • This compound was prepared in 20.5% yield by reaction of l-ch1oro-3- (p-cyclohexylphenyl)-propan-2-ol with l-(m-chlorophenyl) piperazine in a mixture of ethanol and methanol containing potassium hydroxide followed by conversion of the basic product into the required hydrochloride. This had M.P. 202204 C. after crystallisation from isopropanol.
  • EXAMPLE 31 1- 3-(p-cyclohexylphenyl -2-hydroxypropyl] -4- (oethoxyphenyl) piperazine hydrochloride (a) 1 (o-ethoxyphenyl)piperazine hydrochloride.o- Phenetidine (13.6 g.) was added to a solution of bis-(2- chloroethyl)amine hydrochloride (22.2 g.) in n-butanol (60 ml.) and the mixture heated for 30 hours with the addition of two 5.3 g. samples of anhydrous sodium carbonate at 10 hour intervals. The mixture was filtered hot and the filtrate concentrated to half bulk. The product 1 1 (9.7 g.) which crystallised on cooling had M.P. 207209 C. after crystallisation from isopropanol.
  • EXAMPLE 32 1- o-butoxyphenyl -4- [3- (p-cyclohexylphenyl -2-hydroxy-propyl] piperazine hydrochloride (a) 1-(o-butoxyphenyl)piperazine hydrochloride.
  • the product (15.6 g.) was obtained by reaction of bis-(Z-chloroethyl)amine hydrochloride (31.5 g.) with o-butoxyaniline (23.8 g.) in n-butanol (100 ml.) in the presence of anhydrous sodium carbonate (14.8 g.) as described for l-(o-ethoxyphenyl) piperazine hydrochloride in Example 31. It had M.P. 144146 C. after crystallisation from a mixture of isopropanol and ether.
  • EXAMPLE 33 1-[3-(p-cyclohex-1-enylphenyl)-2-hydroxypropyl]-4- (o-methoxyphenyl) piperazine hydrochloride This compound was obtained in 25% yield by reaction of 1-chloro-3-(pcyclohex-1-enylphenyl)-propan-2-ol with l-(o-methoxyphenyl) piperazine in a mixture of methanol and ethanol in the presence of potassium hydroxide, following the procedure described in earlier examples. It had M.P. 179-180 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 34 1- [3 -(p-cyc1opentylphenyl) -2-hydroxypropyl] -4-(omethoxyphenyl) piperazine hydrochloride
  • This compound was prepared in 16% yield by reaction of 1 chloro-3-(p-cyclopentylphenyl)-propan-2-ol with 1- (o-methoxyphenyl) piperazine in ethanolic solution in the presence of potassium hydroxide followed by conversion of the basic product into the hydrochloride. It had M.P. 174176 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 36 1 [3-(p-cyclopentl-enylphenyl)-2-hydroxypropyl] -4- (omethoxyphenyl) piperazine hydrochloride This compound was prepared in 17% yield by reaction of 1-chloro-3-( p-cyclopentl-enylphenyl) -propan-2-ol with l (o-methoxyphenyl) piperazine using the method described in earlier examples. It had M.P. 183-185 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 37 1- [3 (2'-n-butoxy-5-phenyl )phenyl-2-hydroxypropyl]- 4-(o-methoxyphenyl) piperazine hydrochloride This compound was prepared by reaction of l-chloro 3-(2'-n-butoxy-5'-phenyl)-phenylpropan-2-ol with l-(omethoxyphenyl) piperazine as described in earlier examples. It was obtained in 35% yield and had M.P. 160- 162 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 38 1- (m-chlorophenyl -4- 3- (o-methoxyphenyl -2- hydroxypropyl] piperazine A solution of l-(m-chlorophenyl) piperazine dihydrochloride (13.5 g.) in ethanol (100 ml.) was treated with 1-chlor0-3-(o-methoxyphenyl)-propan-2-ol (10 g.) followed at once by a solution of 85% potassium hydroxide (9.5 g.) in methanol ml.) and the mixture was heated under reflux or 10 hours. It was then filtered, concentrated and the residue partitioned between chloroform and water.
  • EXAMPLE 39 1-[3-(2'-n-butoxy-5'-cyclohexylphenyl) 2 hydroxypropyl]-4-(o-methoxyphenyl) piperazine hydrochloride (a) 2-bromo-4-cyclohexylphenol.A solution of pcyclohexylphenol (44 g.) in chloroform (500 ml.) was stirred and treated during 30 minutes with a solution of bromine (13 ml.) in chloroform (15 ml.) and reaction was completed by heating at reflux temperature for 2 hours. The solvent was distilled oil? at reduced pressure and the residual oil was distilled at 0.05 mm. pressure to yield the product (40.5 g.) B.P. 102104 C.
  • EXAMPLE 40 1- [3- (o-cyclohexyloxyphenyl -2-hydroxypropyl] -4- (omethoxyphenyl) piperazine hydrochloride (a) l-chloro 3 (o-cyclohexyloxyphenyl)-propan-2- ol.A Grignard reagent was prepared from o-cyclohexyloxybromobenzene (40.7 g.), ethyl bromide (6.2 ml.) and magnesium (5.75 g.) in ether (400 ml.). This was stirred and treated with a solution of epichlorohydrin (59.2 g.) in ether (50 ml.), added during 30 minutes.
  • EXAMPLE 42 1- (o-acetamidophenyl) -4- [3 (p-cyclohexylphenyl) -2- hydroxypropyl] piperazine hydrochloride
  • This product was prepared in 40% yield by reaction of 1-( o-aminophenyl)-4-[3-(p-cyclohexylphenyl) 2 hydroxypropyl]piperazine hydrochloride with acetyl chloride in 1,2-dichloroethane in the presence of pyridine. It had M.P. 174-176 C. after crystallisation from a mixture of 1,2-dichloroethane and light petroleum (B.P. 40- 60 C.).
  • Example 44(a) The preparation described in Example 44(a) was carried out in more concentrated solution viz in ethanol ml.) and methanol (50 ml.) and the mixture was allowed to stand at room temperature for 6 days. The free base was isolated and converted into the monohydrochloride as described in Example 44(a).
  • EXAMPLE 45 1- [3- (p-biphenylyl) -2-hydroxypropyl] -4- (m-fluorophenyl) piperazine hydrochloride a) l-(p-biphenylyl)-2,3-epoxypropane.-A suspension of l-(p-biphenylyl) 3 chloropropan-Z-ol (49.3 g.) in mixed solutions of water (1 litre) and ethanol (250 ml.) containing sodium carbonate (42.4 g.), was heated with vigorous stirring and the ethanol was allowed to boil ofi. during 1 hour. Heating at 95 C. was then continued for 2 /2 hours.
  • the oil was isolated with chloroform and the chloroform extract was washed with water.
  • the chloroform was distilled off and the residual oil distilled at reduced pressure to yield the epoxide (37.2 g.), B.P. 132 C. at 0.35 mm., M.P. 51 C., after crystallisation from a small amount of methanol.
  • EXAMPLE 46 1 [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- (o fluorophenyl) piperazine hydrochloride (a) l-(p-cyclohexylphenyl)-2,3-epoxypropane.-A suspension of 1 chloro-3-(p-cyclohexylphenyl)-propan-2-ol (37.8 g.) in water (1 litre) and ethanol (250 ml.) was converted into the epoxide using the method described in Example 45 (a). The epoxide had B.P. 104 C. at 0.1 mm.
  • EXAMPLE 47 1 chloro 2-methoxyphenyl)-4-[3-(p-cyclohexylphenyl -2-hydroxypropyl] piperazine hydrochloride (a) 1 (5 chloro 2 methoxyphenyDpiperazine hydrochloride.Tl1is compound (10.4 g.) was obtained by reaction of bis-(2-chloroethyl)amine hydrochloride (55.7 g.) with 5-chloro-2-methoxyaniline (39.4 g.) in n-butanol (180 ml.) in the presence of anhydrous sodium carbonate (27.5 g.) as described for the preparation of l-(o-ethoxyphenyl)-piperazine hydrochloride in Example 31. It had M.P. 218220 C. after crystallisation from 1,2-dichloroethane.
  • EXAMPLE 48 1- [3- p-cyclohexylphenyl -2-hydroxypropyl -4- 5 methyl-2,4-disulphamoylphenyl piperazine To a solution of 1-chloro-3-(p-cyclohexylphenyl)- propan-2-ol (10.1 g.) in 2-methoxyethanol (20 ml.) was added a solution of 1-(5-methyl-2,4-disulphamoyl) piperazine (10.3 g.) in 2-methoxyethanol (230 ml), followed by a solution of 80% potassium hydroxide (2.8 g.) in methanol (30 ml.) and the mixture was heated at reflux temperature for hours.
  • EXAMPLE 49 1- 3- p-cyclohexy1phenyl -2-hydroxypropyl] -4- (p-hydroxyphenyl)piperazine hydrochloride
  • the title compound was prepared in 55% yield by reaction of 1 ehloro 3-(p-cyclohexylphenyl)propan-Z-ol with l-(m-fluorophenyl) piperazine in a mixture of ethanol and methanol in the presence of potassium hydroxide as described in earlier examples. It had M.P. 228230 C. after crystallisation from a mixture of ethanol and ether.
  • EXAMPLE 50 1- 3-(pcyclohexylphenyl -2-hydroxypropyl] -4- (p-hydroxylphenyl)piperazine hydrochloride
  • the title compound was prepared in 74% yield by reaction of 1-chloro-3-(p-cyclohexylphenyl)propan-Z-ol (11.6 g.) with l-(p-hydroxyphenyl) piperazine dihydrobromide (13.3 g.) in a mixture of ethanol (50 ml.) and methanol (50 ml.) in the presence of 85% potassium hydroxide (9.8 g.). The mixture was heated at reflux for 6 hours then poured into water. Neutralisation gave the 16 free base which, on dissolving in ethanol and treatment with hydrogen chloride, yielded the title compound. This (12.4 g.) had M.P. 2479 C. after crystallisation from a mixture of ethanol and ether.
  • R is selected from the group consisting of phenyl and phenyl substituted with a group selected from those consisting of alkyl having from 1 to 4 carbon atoms, alkoxy having from 1 to 4 carbon atoms, fluorine, chlorine, and trifluoromethyl; and their pharmaceutically acceptable acid addition salts.
  • a compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl] 4-o-tolylpiperazine hydrochloride.
  • a compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl]-4-m-tolylpiperazine hydrochloride.
  • a compound according to claim 1 consisting of l- (p chlorophenyl) 4 [3-(p-cyclohexylphenyl)-2-hydroxypropyl]-piperazine hydrochloride.
  • a compound according to claim 1 consisting of 1 o chlorophenyl 4 [3-(p-chlorhexylphenyl)-2-hydroxypropyl]-piperazine dihydrochloride.
  • a compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) Z-hydroxypropyl]-4-o-methoxyphenylpiperazine dihydrochloride.
  • a compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl]-4-(m-methoxyphenyl -piperazine dihydrochloride.
  • a compound according to claim 1 consisting of l- [3 (p cyclohexylphenyl)-2-hydroxypropyl]-4-phenylpiperazine dihydrochloride.
  • a compound according to claim 1 consisting of 1- [3 (p cyclohexyloxyphenyl)-2-hydroxypropyl]-4-(omethoxyphenyl -piperazine hydrochloride.
  • a compound according to claim 1 consisting of 1- [3 (p cyclohexylphenyl) 2-hydroxypropyl]-4-(o-fiuorophenyl)-piperazine hydrochloride.
  • a compound according to claim 1 consisting of l- [3 (p cyclohexylphenyl)-2-hydroxypropyl]-4-(p-fluorophenyl -piperazine hydrochloride.
  • a compound according to claim 1 consisting of 1- (m chlorophenyl) 4 [3 (p-cyclohexylphenyl)-2- hydroxypropyl]-piperazine hydrochloride.
  • a compound according to claim 1 consisting of 1- [3 (p cyclohexylphenyl) 2 hydroxypropy11-4-(oethoxyphenyl)-piperazine hydrochloride.

Abstract

WHEREIN R IS HYDROGEN OR ALKOXY HAVING FROM 1 TO 8 CARBON ATOMS, R1 IS ALKYL HAVING UP TO 10 CARBON ATOMS, ALKOXY HAVING UP TO 10 CARBON ATOMS, CYCLOALKYL HAVING FROM 5 TO 7 CARBON ATOMS, CYCLOALKYLOXY HAVING FROM 5 TO 7 CARBON ATOMS, CYCLOALK-1-ENYL HAVING FROM 5 TO 7 CARBON ATOMS, PHENYL, PHENOXY OR HALOGEN, R2 IS HYDROGEN OR METHYL, R3 IS 2-HYDROXYCYCLOHEXYL, 2-PYRIDYL, PHENYL, DIMETHOXYPHENYL, CHLORONITROPHENYL, CHLOROMETHOXYPHENYL, AND METHYLDISULPHAMOLYPHENYL, PHENYL SUBSTITUTED WITH A GROUP SELECTED FROM THOSE CONSISTING OF ALKYL HAVING UP TO 4 CARBON ATOMS, ALKOXY HAVING FROM 1 TO 4 CARBON ATOMS, FLUORINE, CHLORINE, BROMINE, NITRO, AMINO, SULPHAMOYL, HYDROXY, TRIFLUOROMETHYL AND ACETAMIDO, AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS.

1-((R,R1-PHENYL)-CH2-C(-R2)(-OH)-CH2-),4-R3-PIPERAZINE

NOVEL SUBSTITUTED PIPERAZINE COMPOUNDS OF THE FORMULAE

Description

United States Patent US. Cl. 260-268 PH 13 Claims ABSTRACT OF THE DISCLOSURE Novel substituted piperazine compounds of the formulae -omo on 011216 N-R R1 wherein R is hydrogen or alkoxy having from 1 to 8 carbon atoms;
R is alkyl having up to 10 carbon atoms, alkoxy having up to 10 carbon atoms, cycloalkyl having from 5 to 7 carbon atoms, cycloalkyloxy having from 5 to 7 carbon atoms, cycloalk-l-enyl having from 5 to 7 carbon atoms, phenyl, phenoxy or halogen;
R is hydrogen or methyl;
R is Z-hydroxycyclohexyl, 2-pyridyl, phenyl, dimethoxyphenyl, chloronitrophenyl, chloromethoxyphenyl, and methyldisulphamoylphenyl, phenyl substituted with a group selected from those consisting of alkyl having up to 4 carbon atoms, alkoxy having from 1 to 4 carbon atoms, fluorine, chlorine, bromine, nitro, amino, sulphamoyl, hydroxy, trifluoromethyl and acetamido; and
Their pharmaceutically acceptable acid addition salts.
The compounds of the present invention are effective as central nervous system depressants.
This is a continuation of application Ser. No. 740,881, filed June 28, 1968, now abandoned. This invention relates to organic compounds and has particular reference to substituted piperazines.
It is an object of the invention to provide new piperazine derivatives having the general Formula I below, which are of particular value as drugs acting on the central nervous system.
The compound 1-[3-(p-cyclohexylphenyl)-2-hydroxypropyl] 4 o-methoxyphenylpiperazine dihydrochloride, the product of Example 8, is a central nervous system depressant. Thus it was twice as active as morphine in the mouse tail-pinch test, three times as active as chlorpromazine in the mouse rage test and twice as active as chlorpromazine in the anti-amphetamine test.
Furthermore the products of the examples listed below have shown similar central nervous system activity:
EXAMPLE 1 A X CPZ in mouse rage test. /2 CPZ in antiamphetamine test.
EXAMPLE 2 1.7 X CPZ in reducing spontaneous motor activity.
EXAMPLE 3 2X CPZ in mouse rage test. 4 CPZ in reducing spontaneous motor activity.
3,732,229 Patented May 8, 1973 EXAMPLE 4 1.5 X morphine in tailpinch test. AXCPZ in mouse rage test.
EXAMPLE ll /3 X CPZ in reducing spontaneous motor activity.
EXAMPLE 14 1.8 X CPZ in mouse rage test.
EXAMPLE 16 2.5 x CPZ in mouse rage test.
EXAMPLE 22 Equals CPZ in mouse rage test. /2 x CPZ in reduction of spontaneous motor activity.
EXAMPLE 24 73 CPZ in mouse rage test. 1A CPZ in reduction of spontaneous motor activity.
EXAMPLE 25 2x CPZ in mouse rage test.
EXAMPLE 26 6 X CPZ in mouse rage test. Active in antiamphetamine test.
EXAMPLE 30 Equals CPZ in mouse rage test.
EXAMPLE 31 Equals CPZ in mouse rage test.
CPZ above denotes chlorpromazine.
According to the present invention there are provided novel piperazine derivatives having the general formula where R=hydrogen or alkoxy (containing from 1-8 carbon atoms in a straight or branched chain) R =alkyl, either straight or branched chain containing up to 10 carbon atoms; alkoxy, either straight or branched chain up to 10 carbon atoms; cycloalkyl containing from 5-7 carbon atoms; cycloalkyloxy containing from 5-7 carbon atoms; cycloalk-l-enyl (e.g. cyclohex-lenyl), containing from 5-7 carbon atoms; phenyl, phenoxy or halogen R =hydrogen or methyl R =2-hydroxycyclohexyl; phenyl or mono-, dior trisubstituted phenyl (such substituents include alkyl, containing up to 4 carbon atoms; alkoxy, containing from 1-4 carbon atoms; fluorine; chlorine; bromine; nitro; amino; acylamino; tn'fiuoromethyl; sulphamoyl and hydroxy).
In addition the group R may represent a 2-pyridy1 nucleus.
The compounds of the present invention may be used as the free bases or in the form of their salts with inorganic or organic acids, which in general will be pharmaceutically acceptable in their own right, such for example as hydrochloric, sulphuric, phosphoric, benzoic, citric, maleic, tartaric or salicylic acids.
According to the present invention there is provided a process for the preparation of piperazine derivatives having the general Formula I above which process comprises reacting a chlorohydrin having the formula @wmbwmomcr B1 (where R, and R and R have the same meaning as above) and a base and a substituted piperazine having the formula HN N-R (III) (where R has the same meaning as above) The base is an inorganic base such as potassium hydroxide or sodium carbonate or an organic base in the form of an excess of the substituted piperazine. In the latter case the reaction .may be carried out employing 2 mole equivalents of the substituted piperazine. When potassium hydroxide is employed as the inorganic base the reaction proceeds as shown below:
where R, R, R and R have the same significance as in Formula I.
In some instances it may be convenient to react the chlorohydrin (II) initially with the inorganic base thereby forming the corresponding epoxide (IV) which is subsequently reacted with the substituted piperazine. Thus for example the chlorohydrin (II) may be treated with cold methanolic potassium hydroxide or heated with aqueous The process may be carried out in a variety of solvents such as, for example, alcohols, hydrocarbons, ethers or aqueous alcohols. Reaction temperatures are not critical, but in most cases it was found satisfactory to heat the reactants in ethanol or .methanol at reflux temperature for several hours. The products may be purified by distillation at reduced pressure or by crystallisation from an appropriate solvent. In some cases it was found most convenient to convert the basic product into a suitable salt which could then be purified by crystallisation.
Chlorohydrins of Formula II employed as starting materials in the present invention are described in our British specification No. 1,040,735 together with their preparation.
Following is a description by way of example of methods of carrying the invention into effect.
EXAMPLE 1 1-[3-(p-cyclohexylphenyl)-2-hydroxypropyl]-4-o-tolylpiperazine hydrochloride A solution of 1-chloro-3-(p-cyclohexylphenyl)propan 2-01 (10.1 g.) in methanol (50 ml.) was treated with a solution of potassium hydroxide (11.2 g.) in methanol ml.) followed by l-o-tolylpiperazine dihydrochloride (10 g.). The mixture was heated under reflux for 2 hours and excess of methanol was boiled off and the residue diluted with water. The resultant oil was isolated with chloroform, the chloroform extracts were washed with water and the solvent distilled off, last traces being removed at reduced pressure (25 mm.). The residual oil was dissolved in isopropanol (80 ml.) and treated with a slight excess of hydrogen chloride. The solution was diluted with ether and cooled to 5 C. overnight. The product (9.8 g.) was collected and crystallised from water containing a small amount of ethanol. It had M.P. 23 3235 C.
EXAMPLE 2 1- [3 (p-eyclohexylphenyl -2-hydroxypropyl] -4-m-tolylpiperazine hydrochloride A solution of l-chloro-3-(p-cyclohexylphenyl)propan- 2-01 (10.1 g.) in ethanol (50 ml.) was treated with a solution of 85% potassium hydroxide (10.5 g.) in methanol (60 ml.) followed by a solution of l-(m-tolyl) piperazine dihydrochloride hydrate (10.7 g.) in ethanol (50 ml.) and the mixture was heated under reflux for 10 hours. The excess of alcohol was boiled off, the residue diluted with water and the oil extracted with chloroform. The chloroform extract was washed with water, concentrated, and the last traces of solvent distilled off at reduced pressure (20-25 mm.). The resultant residue was dissolved in 2 volumes of warm ethanol, treated with a slight excess of hydrogen chloride and the solution diluted with ether. The resultant crystalline solid was collected (13 g.) and purified by recrystallisation from a mixture of methanol and ether. It had M.P. 203-205 C.
EXAMPLE 3 l-(p-chlorophenyl) -4-[3-(p-cyclohexylphenyl)-2- hydroxypropyl]piperazine hydrochloride A solution of 1-chloro-3 (p-cyclohexylphenyl)-propan- 2-ol (10.1 g.) in ethanol (50 ml.) was treated with a solution of 85% potassium hydroxide (10.5 g.) in methanol (50 ml.) followed by a solution of l-(p-chlorophenyl) piperazine dihydrochloride (10.8 g.) in ethanol (50 ml.) and the mixture was heated under reflux for 20 hours. The mixture was concentrated to remove most of the alcohol and was then diluted with water. The resultant oily material was extracted with chloroform, the chloroform extract was washed with water and the solvent was distilled off, first at atmospheric pressure and then at reduced pressure. The residual gum Was dissolved in isopropanol treated with a slight excess of hydrogen chloride and the solution diluted with ether. Crystalline material was collected (12 g.) and recrystallised from a mixture of ethanol and ether. It had M.P. 193-195 C.
EXAMPLE 4 1-o-chlorophenyl-4- 3- (p-cyclohexylphenyl) -2-hydroxypropyl] -piperazine dihydrochloride Reaction of 1-chloro-3-p-cyclohexylphenylpropan-Z-ol (6.3 g.) with l-(o-chlorophenyl)piperazine hydrochloride hydrate (6.3 g.) in ethanol ml.), containing 85% potassium hydroxide (3.6 g.), at reflux temperature for 5 hours, followed by isolation of the crude base and treatment of this with hydrogen chloride as described in Example 1, yielded the dihydrochloride (4.7 g.) which had M.P. 177-179 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 5 1- [3- (p-biphenylyl -2-hydroxypropy1] -4-o-chlorophenylpiperazine hydrochloride A solution of 1-p-biphenylyl-3-chloropropan-2-ol (6.2 g.) in ethanol (120 ml.) was treated with a solution of 85 potassium hydroxide (3.6 g.) in methanol (40 ml.) followed by 1-(o-chlorophenyl)-piperazine hydrochloride hydrate (6.3 g.) and the mixture was heated at reflux temperature for 5 hours. The basic product was isolated with chloroform and converted into its hydrochloride salt as described in Example 1. This product (7.3 g.) had M.P. 190-191 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 6 1phenyl-4- 3 2-n-butoxy-5 -phenyl) phenyl-2- hydroxypropyl] piperazine A solution of 1-chloro-3--(2'-n-butoxy-5'-phenyl)-phen ylpropan-2-ol (9.5 g.) in ethanol (100 ml.) was treated With 1- phenyl-piperazine (4.9 g.) followed by a solution of 85% potassium hydroxide (2.1 g.) in methanol (25 ml.) and the mixture was boiled under reflux for 5 hours. It was filtered hot to remove potassium chloride and the base crystallised from the filtrate on cooling. The crystalline material was collected and washed with water to remove admixed potassium chloride. It was then crystallised from ethanol to yield the product (11.8 g.), M.P. 111-113 C.
EXAMPLE 7 1-o-chlorophenyl-4- 3- (p-cyclohexl-enylphenyl) -2- hydroxypropyl]-piperazine hydrochloride A solution of 1-chloro-3-(p-cyclohex-l-enylphenyl)propan-Z-ol (6.25 g.) in ethanol (120 ml.) was treated with a solution of 85% potassium hydroxide (3.6 g.) in methanol (40 ml.) followed at once by l-(o-chlorophenyl) piperazine hydrochloride hydrate and the mixture was heated under reflux for 5 hours. The base was then isolated with chloroform as in previous examples, dissolved in ethanol (75 ml.) and treated with a slight excess of hydrogen chloride. The hydrochloride salt separated on cooling. It (5.8 g.) had M.P. 194.5l96.5 C. after crystallisation from a mixture of isopropanol and ether.
EXAMPLE 8 1- 3- (p-cyclohexylphenyl -2-hydroxypropyl] -4-omethoxyphenylpiperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohexylphenyl)propan- 2-01 (8.8 g.) in ethanol (100 ml.), was treated with a solution of 85% potassium hydroxide (7.25 g.) in methanol (70 ml.) followed by l-(o-methoxyphenyl)-piperazine dihydrochloride (9.3 g.) and the mixture was heated under reflux for 5 hours. The precipitated potassium chloride was filtered off and the ethanol was distilled off, last traces being removed at reduced pressure. The residual base, isolated with chloroform as described'in Example 1, was dissolved in ethanol and treated with a slight excess of hydrogen chloride. The dihydrochloride salt separated from the solution on cooling. It 8.5 g.) had M.P. 181-183 C. after crystallisation from anhydrous ethanol.
EXAMPLE 9 1- [3-(o-biphe11ylyl) -2-hydroxypropyl] -4-o-chlorophenylpiperazine A solution of 1-(o-biphenyly1) 3 chloropropan-2-ol (7.4 g.) in ethanol (140 ml.) was treated with a solution of 85% potassium hydroxide (4.1 g.) in methanol (40 ml.) followed by l-(o-chlorophenyl)-piperazine hydrochloride hydrate (7.5 g.) and the mixture was heated under reflux for 5 hours. The base was isolated with chloroform as described in Example 1. It was purified by crystallisation from ethanol and had M.P. 106l08 C. (yield-78 g.).
EXAMPLE 10 1- 3- (p-biphenylyl -2-hydroxypropyl] -4-o-chlorophenylpiperazine hydrochloride a) 3-(p-biphenylyl) 1,2 epoxypropane.A suspension of l-(p-biphenylyl)-3-chloropropan-2-ol (49.3 g.) in water (1 litre) and ethanol (250 ml.) containing sodium carbonate (42.4 g.) was heated with efficient stirring for 4 hours with free evaporation of the ethanol. The resultant oil was isolated with chloroform to yield the epoxide (37.2 g.) B.P. 130132 C. at 0.35 mm., M.P. 51 C. (from methanol).
(b) A solution of 3-(p-biphenylyl)-1,2-epoxypropane (2.10 g.) in benzene (20 ml.) was treated with a solution of 1-(o-chlorophenyl)piperazine (1.97 g.) in benzene (20 ml.) and the solution Was heated at reflux temperature for 3 hours. The solution was cooled and treated with a slight excess of hydrogen chloride gas. The hydrochloride salt which separated was collected (3.0 g.) and purified by crystallisation from a mixture of ethanol and ether. It had M.P. 190191 C. and was identical with the material described in Example 5.
EXAMPLE 11 l- (o-methoxyphenyl -4- 3- (p-phenoxyphenyl -2- hydroxypropyl] piperazine dihydrochloride A solution of 1-chloro-3-(p-phenoxyphenyl)-propan-2- 01 (8.15 g.) in methanol (20 ml.) was treated with a solution of 85 potassium hydroxide (3.82 g.) in methanol (30 ml.) followed by l-(o-methoxyphenyl) piperazine dihydrochloride (8.51 g.) and the mixture was heated at reflux temperature for 20 hours. The excess of methanol was boiled off, the residual oil extracted with ether and the extract Washed With Water and dried with anhydrous sodium sulphate. The ether was distilled off, the residual oil was dissolved in a small volume of ethanol and treated with a slight excess of hydrogen chloride gas. Dilution with ether furnished the dihydrochloride salt (7.6 g.). The product had M.P. 188-l91 C. after crystallisation from ethanol.
EXAMPLE 12 1-(2-hydroxycyclohexyl)-4-[3 (p-cyclohexylphenyl)-2- hydroxypropyl] piperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohexylphenyl)propan- 2-ol (10.1 g.) in ethanol ml.) was treated with a. solution of potassium hydroxide (2.8 g.) in methanol (20 ml.) followed by l-(o-hydroxycyclohexyl) piperazine (7.36 g.) and the mixture heated under reflux for 12 hours. It was then concentrated to remove most of the alcohol, water was added and the basic product isolated with ether and converted into the dihydrochloride salt as described in Example 11. The product (7.8 g.) had M.P. 256260 C. after crystallisation from methanol.
EXAMPLE 13 l-(p-chlorophenyl) -4-[3-(p-cyclohex-1-enylphenyl)-2- hydroxypropyl] -piperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohex-l-enylphenyl)- propan-Z-ol (7.5 g.) in ethanol ml.) was treated with a solution of 85 potassium hydroxide (6.6 g.) in methanol (40 ml.) followed by l-(p-chlorophenyl) piperazine dihydrochloride (8.1 g.) and the mixture heated under reflux for 12 hours. The basic product was isolated with chloroform as described in earlier examples and converted into the dihydrochloride in ethanolic solution. The product (3.8 g.) had M.P. 209-211 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 14 1- [3 (p-cyclohexylphenyl -2-hydroxypropyl] -4- (m-methoxyphenyl)piperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohexylphenyl) propan- 2-01 (10.1 g.) in ethanol (150 ml.) was treated with 1- 7 (m-methoxyphenyl)piperazine dihydrochloride (10.6 g.) followed by a solution of 85 potassium hydroxide (8.6 g.) in methanol (50 ml.) and the mixture refluxed for 12 hours. The base was isolated with chloroform and converted into the dihydrochloride as described in earlier examples. The product (9.85 g.) had M.P. 216217 C. after crystallisation from ethanol.
EXAMPLE 15 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl -4- (p-methoxyphenyl) -piperazine dihydrochloride This compound was prepared in the same way as the m-methoxyphenyl analogue described in Example 14 except that l-(p-methoxyphenyl)-piperazine dihydrochloride was used in place of 1-(m-methoxyphenyl)-piperazine dihydrochloride. The dihydrochloride g.) had M.P. 195- 197 C. after crystallisation from the mixture of ethanol and ether.
EXAMPLE 16 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- phenylpiperazine dihydrochloride A solution of 1-chloro-3-(p-cyclohexyl)phenylpropan- 2-01 (10.1 g.) in ethanol (150 ml.) was treated with 1- phenylpiperazine (6.5 g.) followed by a solution of 85% potassium hydroxide (2.8 g.) in methanol (25 ml.) and the mixture was refluxed for 12 hours. The base was isolated with chloroform and converted into a dihydrochloride as described in earlier examples. The product (5 g.) had M.P. 103105 C. after crystallisation from methanol.
EXAMPLE 17 1-(o-chlorophenyl)-4-[3- (p-chlorophenyl)-2- hydroxypropyl] piperazine hydrochloride A solution of l-(o-chlorophenyl) piperazine hydrochloride hydrate (6.3 g.) in ethanol (60 ml.) was treated with a solution of 1-chloro-3-(p-chlorophenyl)-propan- 2-01 (5.1 g.), in ethanol (40 m1.) followed by a solution of 85% potassium hydroxide (3.6 g.) in methanol (40 ml.) and the mixture was heated under reflux for 5 hours. The precipitated potassium chloride was filtered off, the filtrate concentrated to remove ethanol, and the basic residue partitioned between chloroform and water. The chloroform extract was concentrated, the residual oil was dissolved in an equal volume of ethanol and treated with a slight excess of hydrogen chloride. Dilution with ether yielded the hydrochloride (8.4 g.) which had M.P. 181- 183 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 18 1- 3-p-hexylphenyl -2-hydroxypropyl] -4- (o-methoxyphenyl)piperazine hydrochloride (a) l-(p-bromophenyl)hexane.-Bromine (74.2 g.) was added dropwise with stirring to l-phenylhexane (71.6 g.) in the presence of iron powder (2.5 g.) as catalyst. After the addition was complete the mixture was allowed to stand overnight when chloroform (100 ml.) was added and the liquid washed with water, sodium hydroxide solution, sodium sulphite solution and twice more with water. The liquid was then dried with anhydrous sodium sulphate and the solvent distilled off at reduced pressure. The residual liquid was fractionally distilled at reduced pressure to give the product in 57% yield, B.P. 87-89" C. at 0.65 mm.
(b) 1-chloro-3-(p-hexylphenyl)propan-2-ol.A solution of 1-(p-bromophenyl)hexane (90.4 g.) in ether (325) ml.) plus tetrahydrofuran (75 ml.) and ethyl bromide (20.5 g.) was added dropwise to activated magnesium (13.5 g.). When the reaction was complete the mixture was stirred for 2 hours and treated with epichlorohydrin (117 g.) added dropwise during 1 hour, then the mixture was stirred for 2 hours further. It was then cooled in icewater and decomposed by the dropwise addition of 5 N 8 hydrochloric acid (300 ml.). The organic layer was separated, washed twice with water and dried over anhydrous sodium sulphate. It was then concentrated and the residual oil distilled at reduced pressure to give the chlorohydrin, B.-P. 132-134 C. at 0.08 mm. in 69.2% yield.
(c) The foregoing chlorohydrin (11.2 g.) was added to a solution of 1-(o-methoxyphenyl)piperazine (11.3 g.) and potassium hydroxide (8 g.) in ethanol ml.) and the mixture was heated under reflux for 12 hours. The ethanol was boiled off and the residue partitioned between chloroform and water. The chloroform layer was washed with water, dried over anhydrous sodium sulphate and the chloroform distilled off. The residual oil was treated with a slight excess of ethanolic hydrogen chloride and the solution diluted with ether when the hydrochloride crystallised. It (8.6 g.) had M.P. 133 to 135 C., after crystallisation from isobutyl methyl ketone.
EXAMPLE l9 1-[ 3-p-cyclohexylphenyl) -2-hydroxypropyl] -4- (ptolyl)piperazine hydrochloride Reaction of 1-chloro-3-p-cyclohexylphenylpropan-Z-ol (12.6 g.) with l-p-tolylpiperazine hydrochloride (10.6 g.) in ethanol (100 ml.) containing 85 potassium hydroxide (7.5 g.) at reflux temperature for 10 hours, followed by isolation of the crude base and treatment of this with ethanolic hydrogen chloride as described in Example 1, yielded the hydrochloride (4.5 g.) which had M.P. 204206 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 20 1(m-bromophenyl)-4-[3-(p-cyclohexy1phenyl) -2- hydroxypropyl]piperazine hydrochloride (a) 1-(m-bromophenyl)piperazine hydrochloride.A mixture of rn-bromoaniline (68.8 g.) and bis-(2-chloroethyl) amine hydrochloride (71.4 g.) in ethanol (250 ml.) was heated at reflux temperature for 10 hours when anhydrous sodium carbonate (21.2 g.) was added to the mixture and heating was continued for a further 10 hours. The mixture was filtered hot, concentrated to half-bulk and cooled when the product separated. It (22.7 g.) had M.P. 2172l9 C. after crystallisation from ethanol.
(b) The title compound was obtained in 43% yield by reaction of 1-chloro-3-p-cyclohexyl phenylpropan-Z- 01 with m-bromophenylpiperazine hydrochloride in ethanolic potassium hydroxide solution followed by conversion of the base obtained into the hydrochloride and had M.P. 192-194 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 21 1- [3 (p-cyclohexylphenyl -2-hydroxypropyl -4- (onitrophenyl) piperazine hydrochloride This compound (12.8 g.) was obtained by reaction of 1-chloro-3-p-cyclohexylphenylpropan-Z-ol (10.1 g.) with l-o-nitrophenylpiperazine (8.3 g.) in ethanol (70 ml.) containing potassium hydroxide at reflux temperature for 8 hours. The crude base was isolated and converted into the hydrochloride which had M.P. 180182 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 22 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- (2- pyridyl) piperazine hydrochloride This compound was prepared in 66% yield by reaction of 1-chloro-3-pcyclohexylphenylpropan-Z-ol with 1-(2'- pyridyl) piperazine in ethanol in the presence of potassium hydroxide followed by conversion of the base into the hydrochloride as described in earlier Examples. The hydrochloride had M.P. 223224 C. after crystallisation from isopropanol.
EXAMPLE 23 1-[3-p-(cyclohexylphenyl)-2-hydroxy-2-methylpropy1]- 4-o-methoxy-phenylpiperazine hydrochloride (a) 1-chloro-3-(p-cyclohexylphenyl) 2 methylpropan-2-ol.--To a Grignard solution prepared from magnesium (4.8 g.) and p-bromophenylcyclohexane (48 g.) in ether (250 ml.), fl-methylepichlorohydrin (44.4 g.) was added dropwise with stirring during 1 hour and stirring was continued for a further 2 hours. The mixture was then cooled and decomposed by the careful addition of 5 N hydrochloric acid (85 ml.). The ether layer was washed with water, dried over anhydrous sodium sulphate, the ether was distilled off and the residual oil distilled at reduced pressure to yield the chlorohydrin (18.6 g.), B.P. 150-153 C., at 0.4 mm.
(b) The foregoing chlorohydrin g.) was added to a solution of l-(o-methoxyphenyl) piperazine dihydrochloride (10 g.) in ethanol (50 ml.) and this was treated with a solution of 80% potassium hydroxide (8 g.) in methanol (50 ml.). The mixture was heated at reflux temperature for 12 hours when the crude basic product was isolated and converted into the hydrochloride salt as described in earlier examples to give the hydrochloride in 58% yield, M.P. 222-224" C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 24 1- [3 (p-cyclohexyloxyphenyl) -2-hydroxypropyl] -4- omethoxyphenyl) piperazine hydrochloride (a) 1-chloro-3-(p-cyclohexyloxyphenyl)propan-Z-oL- A Grignard solution was prepared from p-bromophenoxycyclohexane (92.9 g.) and magnesium (13.2 g.) in ether 400 ml. This solution was stirred and treated with epichlorohydrin (102 g.) added at such a rate that the reaction was maintained at gentle reflux temperature. The mixture was allowed to stand overnight when it was cooled and decomposed by the careful addition of 5 N hydrochloric acid (250 ml.). The ether layer was Separated, washed with water, dried over anhydrous sodium sulphate and the ether was boiled off. The residual oil was distilled at reduced pressure to yield the chlorohydrin (46.2 g.), B.P. 144-146 C. at 0.2 mm.
(b) Reaction of the foregoing chlorohydrin with 1-(omethoxyphenyl) piperazine as described in earlier exam ples gave the product, isolated as the hydrochloride, in 52% yield, M.P. 147-149 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 25 1- [3 p-cyclohexylphenyl -2-hydroxypropyl] -4- (ofiuorophenyl) piperazine hydrochloride This compound was prepared by reaction of l-chloro- 3-(p-cyclohexylphenyl)-propan-2-ol with 1-(0 fluorophenyl)piperazine using the experimental procedure described in Example 3. It was obtained in 47% yield and had M.P. 192.5-193.5 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 26 1- [3- (p-cyclohexylphenyl) -2-hydroxypropyl] -4- (pfiuorophenyl) piperazine hydrochloride This compound was obtained in 59% yield by reaction of 1-chloro-3-(p-cyclohexylphenyl)propan-2-ol with 1-(p fluorophenyl)-piperazine as described in earlier examples. It had M.P. 179-180 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 27 1- [3-(p-cyclohexylphenyl) -2-hydroxypropyl] -4- (mtrifluoromethylphenyl) piperazine hydrochloride Reaction of 1-chloro-3-(p-cyclohexylphenyl)-propan- 2-o1 with 1-(m-trifluorornethylphenyl)piperazine using the method described in Example 3 gave this product in 10 50% yield, M.P. 189-191 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 28 l- (o-aminophenyl) -4- 3- (p-cyclohexylphenyl) -2- hydroxypropyl] piperazine hydrochloride A solution of 1-[3-(p-cyclohexylphenyl)-2-hydroxypropyl]-4-(o-nitrophenyl) piperazine hydrochloride (11.5 g.) (Example 21) in ethanol (100 ml.) was treated with 5% palladised charcoal catalyst (2 g.) and hydrogenated at atmospheric pressure when 1520 ml. of hydrogen was absorbed in 1 hour. The mixture was filtered, concentrated and diluted with ether to yield the product (5.61 g.) M.P. 229-231 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 29 1-[3-(p-2-ethylbutylphenyl) -2-hydroxypropyl] -4- (omethoxyphenyl) piperazine hydrochloride (a) 3-(p-bromobenzyl) pentane.Bromine (24 g.) was added dropwise with stirring to 3-benzylpentane (24.5 g.) in the presence of iron powder (2 g.) as catalyst. When the addition was complete, stirring was continued for 6 hours and the mixture was allowed to stand overnight. It was then diluted with chloroform (50 mL), washed successively with water, dilute sodium bicarbonate solution and water and dried over anhydrous sodium sulphate. The chloroform was distilled off at reduced pressure and the residual oil distilled at 0.15 mm. pressure to give the product (54.5% yield), B.P. 63 C.
(b) 1-chloro-3- [4- (Z-ethylbutyl phenyl] propan-2-ol. A Grignard reagent was prepared from the foregoing bromo compound (18.8 g.), ethyl bromide (2.7 g.) and magnesium (2.4 g.) in ether (100 ml.). This was stirred and treated with epichlorohydrin (18.5 g.) added dropwise during 30 minutes and stirring was continued for 2 hours further. The reaction mixture was then cooled and decomposed by the careful addition of 5N hydrochloric acid (100 ml.). The ether layer was separated, washed with water, dried over anhydrous sodium sulphate and the ether distilled off. The residual oil was distilled at reduced pressure to yield the chlorohydrin (12.5 g.), B.P. 124 C. at 0.1 mm.
(c) A solution of the foregoing chlorohydrin (7.0 g.) in ethanol (50 ml.) was treated with 1-(o-methoxyphenyl) piperazine (6.3 g.) followed by a solution of potassium hydroxide (3.92 g.) in methanol (30 ml.) and the mixture was heated under reflux for 10' hours. The basic product was isolated as described in earlier examples and converted into the hydrochloride in ethanolic solution. This (3.89 g.) had M.P. 137-139 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 30 1- (m-chlorophenyl) -4- [3 (p-cyclohexylphenyl) -2-hydroxypropyl]-piperazine hydrochloride This compound was prepared in 20.5% yield by reaction of l-ch1oro-3- (p-cyclohexylphenyl)-propan-2-ol with l-(m-chlorophenyl) piperazine in a mixture of ethanol and methanol containing potassium hydroxide followed by conversion of the basic product into the required hydrochloride. This had M.P. 202204 C. after crystallisation from isopropanol.
EXAMPLE 31 1- 3-(p-cyclohexylphenyl -2-hydroxypropyl] -4- (oethoxyphenyl) piperazine hydrochloride (a) 1 (o-ethoxyphenyl)piperazine hydrochloride.o- Phenetidine (13.6 g.) was added to a solution of bis-(2- chloroethyl)amine hydrochloride (22.2 g.) in n-butanol (60 ml.) and the mixture heated for 30 hours with the addition of two 5.3 g. samples of anhydrous sodium carbonate at 10 hour intervals. The mixture was filtered hot and the filtrate concentrated to half bulk. The product 1 1 (9.7 g.) which crystallised on cooling had M.P. 207209 C. after crystallisation from isopropanol.
(b) The title compound was obtained in 26.7% yield by reaction of 1-chloro-3-(p-cyclohexylphenyl)-propan-2- 01 with l-(o-ethoxyphenyl) piperazine hydrochloride in a mixture of ethanol and methanol containing potassium hydroxide, followed by conversion of the basic product into the required hydrochloride. This had M.P. 170-172" C. after crystallisation from a mixture of isopropanol and ether.
EXAMPLE 32 1- o-butoxyphenyl -4- [3- (p-cyclohexylphenyl -2-hydroxy-propyl] piperazine hydrochloride (a) 1-(o-butoxyphenyl)piperazine hydrochloride.The product (15.6 g.) was obtained by reaction of bis-(Z-chloroethyl)amine hydrochloride (31.5 g.) with o-butoxyaniline (23.8 g.) in n-butanol (100 ml.) in the presence of anhydrous sodium carbonate (14.8 g.) as described for l-(o-ethoxyphenyl) piperazine hydrochloride in Example 31. It had M.P. 144146 C. after crystallisation from a mixture of isopropanol and ether.
-(b) The title compound was obtained in 32% yield by reaction of 1 chloro-3-(p-cyclohexylphenyl)-propan-2-ol with l-(o-butoxyphenyl) piperazine hydrochloride using the procedure described in earlier examples. It had M.P. 174-176 C. after crystallisation from a mixture of 1,2- dichloroethane and light petroleum (B.P. 6080 C.).
EXAMPLE 33 1-[3-(p-cyclohex-1-enylphenyl)-2-hydroxypropyl]-4- (o-methoxyphenyl) piperazine hydrochloride This compound Was obtained in 25% yield by reaction of 1-chloro-3-(pcyclohex-1-enylphenyl)-propan-2-ol with l-(o-methoxyphenyl) piperazine in a mixture of methanol and ethanol in the presence of potassium hydroxide, following the procedure described in earlier examples. It had M.P. 179-180 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 34 1- [3 -(p-cyc1opentylphenyl) -2-hydroxypropyl] -4-(omethoxyphenyl) piperazine hydrochloride This compound was prepared in 16% yield by reaction of 1 chloro-3-(p-cyclopentylphenyl)-propan-2-ol with 1- (o-methoxyphenyl) piperazine in ethanolic solution in the presence of potassium hydroxide followed by conversion of the basic product into the hydrochloride. It had M.P. 174176 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 35 1-[3-(p-cyclohept-l-enylphenyl)-2-hydroxypropyl-4-(ornethoxyphenyl) piperazine hydrochloride This product was prepared in 26% yield by reaction of 1-chloro-3-(p-cyclohept-l-enylphenyl)-propan-2-ol with l-(o-methoxyphenyl)-piperazine following the procedure described in earlier examples. It had M.P. 152153 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 36 1 [3-(p-cyclopentl-enylphenyl)-2-hydroxypropyl] -4- (omethoxyphenyl) piperazine hydrochloride This compound was prepared in 17% yield by reaction of 1-chloro-3-( p-cyclopentl-enylphenyl) -propan-2-ol with l (o-methoxyphenyl) piperazine using the method described in earlier examples. It had M.P. 183-185 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 37 1- [3 (2'-n-butoxy-5-phenyl )phenyl-2-hydroxypropyl]- 4-(o-methoxyphenyl) piperazine hydrochloride This compound was prepared by reaction of l-chloro 3-(2'-n-butoxy-5'-phenyl)-phenylpropan-2-ol with l-(omethoxyphenyl) piperazine as described in earlier examples. It was obtained in 35% yield and had M.P. 160- 162 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 38 1- (m-chlorophenyl -4- 3- (o-methoxyphenyl -2- hydroxypropyl] piperazine A solution of l-(m-chlorophenyl) piperazine dihydrochloride (13.5 g.) in ethanol (100 ml.) was treated with 1-chlor0-3-(o-methoxyphenyl)-propan-2-ol (10 g.) followed at once by a solution of 85% potassium hydroxide (9.5 g.) in methanol ml.) and the mixture was heated under reflux or 10 hours. It was then filtered, concentrated and the residue partitioned between chloroform and water. The chloroform layer was washed with water, dried over anhydrous sodium sulphate and the chloroform was then distilled off at reduced pressure. The viscous residue was dissolved in ethanol (40 ml.) when the basic product crystallised (yield 12 g.). It had M.P. 899l C. after crystallisation from ethanol.
EXAMPLE 39 1-[3-(2'-n-butoxy-5'-cyclohexylphenyl) 2 hydroxypropyl]-4-(o-methoxyphenyl) piperazine hydrochloride (a) 2-bromo-4-cyclohexylphenol.A solution of pcyclohexylphenol (44 g.) in chloroform (500 ml.) was stirred and treated during 30 minutes with a solution of bromine (13 ml.) in chloroform (15 ml.) and reaction was completed by heating at reflux temperature for 2 hours. The solvent was distilled oil? at reduced pressure and the residual oil was distilled at 0.05 mm. pressure to yield the product (40.5 g.) B.P. 102104 C.
(b) 2-n-butoxy-5-cyclohexylbromobenzene.A solution of 2-bromo-4-cyclohexylphenol (51 g.) in ethanol (300 ml.) containing potassium hydroxide (13.2 g.) was treated with n-bromobutane (28 g.) and the mixture was heated under reflux for 5 hours. It was then concentrated, poured into water (500 ml.) and the product isolated with chloroform. The chloroform solution was washed with water, dried over anhydrous sodium sulphate and the chloroform was distilled off at reduced pressure. The residual oil was fractionated at 0.3 mm. pressure to yield the product, B.P. 151 C. (yield 44.6 g.).
(c) 1-chloro-3-(2-n-butoxy 5 cyclohexyl)-phenylpropan-2-ol.-To a Grignard reagent prepared from 2-nbutoxy-5-cyclohexylbromobenzene (28.2 g.), ethyl bromide (3.4 ml.) and magnesium (3.25 g.) in a mixture of ether (225 ml.) and tetrahydrofuran (75 ml.) was added a solution of epichlorohydrin (33.3 g.) in a mixture of ether (20 ml.) and tetrahydrofuran (10 ml.) during 30 minutes. The mixture was stirred for 2 hours and was then cooled and decomposed by the careful addition of 5 N hydrochloric acid ml.). The ether layer was separated, washed with water and dried over anhydrous sodium sulphate. The ether was distilled oflf and the residual oil distilled at 0.05 mm. pressure to yield the chlorohydrin (14.1 g.), B.P. 168 C.
((1) Reaction of the foregoing chlorohydrin with l-(omethoxyphenyl) piperazine as described in earlier examples gave the title compound in 37.5% yield, M.P. l8l-183 C., after crystallisation from a mixture of ethanol and ether.
EXAMPLE 40 1- [3- (o-cyclohexyloxyphenyl -2-hydroxypropyl] -4- (omethoxyphenyl) piperazine hydrochloride (a) l-chloro 3 (o-cyclohexyloxyphenyl)-propan-2- ol.A Grignard reagent was prepared from o-cyclohexyloxybromobenzene (40.7 g.), ethyl bromide (6.2 ml.) and magnesium (5.75 g.) in ether (400 ml.). This was stirred and treated with a solution of epichlorohydrin (59.2 g.) in ether (50 ml.), added during 30 minutes.
Stirring was continued for a further 2 hours then the mixture was cooled and decomposed by the careful addition of N hydrochloric acid (100 ml.). The ether layer was separated, washed twice with water, dried over sodium sulphate and the ether distilled off. The residual oil was distilled at 0.075 mm. pressure to yield the chlorohydrin (23.3 g.), B.P. 138-140 C.
(b) Reaction of the foregoing chlorohydrin with l- (o-methoxyphenyl) piperazine by the method described in earlier examples gave a 24% yield of the title compound, M.P. 174176 C., after crystallisation from a mixture of ethanol and ether.
EXAMPLE 41 1- 3 (p-cyclohexylphenyl) -2-hydroxypropyl] -4- (2,4- dimethoxyphenyl) piperazine (a) 1 (2,4 dimethoxyphenyl)piperazine hydrochloride.-This compound (28.2 g.) was obtained by reaction of bis-(2-chloroethyl)amine hydrochloride (55.7 g.) with 2,4-dimethoxyaniline (38.25 g.) in n-butanol (180 ml.) in the presence of anhydrous sodium carbonate (26.5 g.) as described for the preparation of 1-(o-ethoxyphenyl) piperazine hydrochloride in Example 31. It had M.P. 228-230 C. after crystallisation from ethanol.
(b) A solution of 1-chloro-3-(p-cyclohexylphenyl) propan-2-ol (12.6 g.) in ethanol (110 ml.) was treated with 1-(2,4-dimethoxyphenyl)piperazine hydrochloride (12.93 g.) followed by a solution of 85% potassium hydroxide (6.91 g.) in methanol (40 m1.) and the mixture was heated under reflux for 12 hours. The mixture was cooled, poured into water and the oil extracted with three portions of chloroform. The chloroform extracts were washed with water, dried with anhydrous sodium sulphate and the chloroform distilled off, last traces of solvent being removed at reduced pressure. The residual oil was dissolved in warm ethanol when the title compound crystallised. It (10.6 g.) had M.P. 112-l14 C. after crystallisation from ethanol.
EXAMPLE 42 1- (o-acetamidophenyl) -4- [3 (p-cyclohexylphenyl) -2- hydroxypropyl] piperazine hydrochloride This product was prepared in 40% yield by reaction of 1-( o-aminophenyl)-4-[3-(p-cyclohexylphenyl) 2 hydroxypropyl]piperazine hydrochloride with acetyl chloride in 1,2-dichloroethane in the presence of pyridine. It had M.P. 174-176 C. after crystallisation from a mixture of 1,2-dichloroethane and light petroleum (B.P. 40- 60 C.).
EXAMPLE 43 1-(4-chloro-2-nitrophenyl) -4-[S-(p-cyclohexylphenyl)-2- hydroxypropyl] piperazine hydrochloride (a) 1-(4 chloro-2-nitrophenyl)piperazine hydrochloride.A mixture of anhydrous piperazine (51.6 g.) and 2,5-dichloronitrobenzene (38.4 g.) dissolved in n-butanol (250 ml.), was heated at reflux temperature for 6 hours. It was then cooled, poured into water and basified by the addition of a solution of sodium hydroxide (10 g.) in water (100 ml.). The mixture was extracted with four, 100 ml. portions of ether and the ether extracts were combined and concentrated. The residual oil was dissolved in a small amount of ethanol and treated with a slight excess of ethanolic hydrogen chloride. The product (26.5 g.) which separated had M.P. 239-240 C. after crystallization from a mixture of ethanol and ether.
(b) The title compound was prepared in 65% yield by reaction of 1 chloro-3-(p-cyclohexylphenyl)propan-Z-ol with 1 (4-chloro-2-nitrophenyl)piperazine hydrochloride in a mixture of methanol and ethanol containing 2 equivalents of potassium hydroxide, as described in earlier examples. It had M.P. 215-216 C. after crystallisation from a mixture of ethanol and ether.
1 4 EXAMPLE 44 1- 3- (p-cyclohexylphenyl) -2-hydroxypropyl] -4- (omethoxyphenyl) piperazine monohydrochloride (a) A solution of 1-chloro-3-(p-cyclohexylphenyl)propan-2-ol (25.2 g.) in ethanol (250 ml.) was treated with a solution of potassium hydroxide (14.5 g.) in methanol (100 ml.) followed by 1- (o-methoxyphenyD-piperazine monohydrochloride (22.8 g.) and the mixture was heated under reflux for 5 hours. The free base was isolated with chloroform as described in Example 8. It was then dissolved in a minimum of ethanol and treated with a solution of hydrogen chloride (3.7 g.) in ethanol (20 ml.). The crystalline product (28 g.) which separated on dilution of the solution with ether was purified by crystallisation from a mixture of 1,2-dichloroethane and light petroleum (B.P. 60-80 C.) and yielded the monohydrochloride, M.P. 199-201 C.
(b) The same product was obtained in 47% yield when l-chloro-3-(p-cyclohexylphenyl)propan-2-ol (5.05 g.) was reacted with 1-(o-methoxyphenyl)piperazine hydrochloride (4.37 g.) in tertiary butanol ml.) containing 85% potassium hydroxide (3.08 g.) at reflux temperature for 2 hours followed by isolation of the base as described in earlier examples and conversion into the monohydrochloride as described above.
(0) The preparation described in Example 44(a) was carried out in more concentrated solution viz in ethanol ml.) and methanol (50 ml.) and the mixture was allowed to stand at room temperature for 6 days. The free base was isolated and converted into the monohydrochloride as described in Example 44(a). The product (34 g.), M.P. 199-201 C. [after crystallisation from a mixture of 1,2-dichloroethane and light petroleum (B.P. 60-80 C.)], was identical with that described in Example 44(a).
EXAMPLE 45 1- [3- (p-biphenylyl) -2-hydroxypropyl] -4- (m-fluorophenyl) piperazine hydrochloride a) l-(p-biphenylyl)-2,3-epoxypropane.-A suspension of l-(p-biphenylyl) 3 chloropropan-Z-ol (49.3 g.) in mixed solutions of water (1 litre) and ethanol (250 ml.) containing sodium carbonate (42.4 g.), was heated with vigorous stirring and the ethanol was allowed to boil ofi. during 1 hour. Heating at 95 C. was then continued for 2 /2 hours. The oil was isolated with chloroform and the chloroform extract was washed with water. The chloroform was distilled off and the residual oil distilled at reduced pressure to yield the epoxide (37.2 g.), B.P. 132 C. at 0.35 mm., M.P. 51 C., after crystallisation from a small amount of methanol.
(b) A solution of the foregoing epoxide (5.65 g.) in toluene (10 ml.) was treated with a solution of 1-(mfluorophenyl)piperazine (4.87 g.) in toluene (20 ml.) and the mixture was allowed to stand at room temperature for 2 days. The toluene was distilled off at reduced pressure and the residual oil was dissolved in ether and treated with hydrogen chloride. The resultant solid (9.6 g.) was crystallised from a mixture of ethanol and ether to yield the hydrochloride, M.P. 200 to 202 C.
EXAMPLE 46 1 [3- (p-cyclohexylphenyl) -2-hydroxypropyl]-4- (o fluorophenyl) piperazine hydrochloride (a) l-(p-cyclohexylphenyl)-2,3-epoxypropane.-A suspension of 1 chloro-3-(p-cyclohexylphenyl)-propan-2-ol (37.8 g.) in water (1 litre) and ethanol (250 ml.) was converted into the epoxide using the method described in Example 45 (a). The epoxide had B.P. 104 C. at 0.1 mm.
(b) A solution of the foregoing epoxide (4 g.) in toluene (20 ml.) was added to a solution of l-(o-fiuorophenyl)piperazine (3.31 g.) in toluene (15 ml.) and the mixture was heated on the steam bath for 4 hours. The toluene was distilled off at reduced pressure and the residual oil was dissolved in dry ethanol and treated with hydrogen chloride. Dilution with ether furnished the hydrochloride salt (5.2 g.). This had M.P. 195197 C. after crystallisation from a mixture of ethanol and ether. It was identical with the product described in Example 25.
EXAMPLE 47 1 chloro 2-methoxyphenyl)-4-[3-(p-cyclohexylphenyl -2-hydroxypropyl] piperazine hydrochloride (a) 1 (5 chloro 2 methoxyphenyDpiperazine hydrochloride.Tl1is compound (10.4 g.) was obtained by reaction of bis-(2-chloroethyl)amine hydrochloride (55.7 g.) with 5-chloro-2-methoxyaniline (39.4 g.) in n-butanol (180 ml.) in the presence of anhydrous sodium carbonate (27.5 g.) as described for the preparation of l-(o-ethoxyphenyl)-piperazine hydrochloride in Example 31. It had M.P. 218220 C. after crystallisation from 1,2-dichloroethane.
(b) A solution of 1-chloro-3-(p-cyclohexylphenyl) propan-Z-ol (12.6 g.) in isopropanol (125 ml.) was treated with a solution of 85% potassium hydroxide (6.91 g.) in methanol (40 ml.) followed by 1-(5-chloro- 2-methoxyphenyl)piperazine hydrochloride (13.16 g.) and the mixture was heated under reflux for 8 hours. The base was isolated with chloroform and converted into the hydrochloride as described in earlier examples. This (14.4 g.) has M.P. l84186 C. after crystallisation from 1,2-dichloroethane.
EXAMPLE 48 1- [3- p-cyclohexylphenyl -2-hydroxypropyl -4- 5 methyl-2,4-disulphamoylphenyl piperazine To a solution of 1-chloro-3-(p-cyclohexylphenyl)- propan-2-ol (10.1 g.) in 2-methoxyethanol (20 ml.) was added a solution of 1-(5-methyl-2,4-disulphamoyl) piperazine (10.3 g.) in 2-methoxyethanol (230 ml), followed by a solution of 80% potassium hydroxide (2.8 g.) in methanol (30 ml.) and the mixture was heated at reflux temperature for hours. The solvent was distilled 01f at reduced pressure and the residual solid was extracted with boiling ethanol. Dilution of the ethanol with ether yielded the solid product (8.4 g.) which had M.P. 130-131" C. (decomp.) after crystallisation from a mixture of toluene and light petroleum (B.P. 80100 C.).
EXAMPLE 49 1- 3- p-cyclohexy1phenyl -2-hydroxypropyl] -4- (p-hydroxyphenyl)piperazine hydrochloride The title compound was prepared in 55% yield by reaction of 1 ehloro 3-(p-cyclohexylphenyl)propan-Z-ol with l-(m-fluorophenyl) piperazine in a mixture of ethanol and methanol in the presence of potassium hydroxide as described in earlier examples. It had M.P. 228230 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 50 1- 3-(pcyclohexylphenyl -2-hydroxypropyl] -4- (p-hydroxylphenyl)piperazine hydrochloride The title compound was prepared in 74% yield by reaction of 1-chloro-3-(p-cyclohexylphenyl)propan-Z-ol (11.6 g.) with l-(p-hydroxyphenyl) piperazine dihydrobromide (13.3 g.) in a mixture of ethanol (50 ml.) and methanol (50 ml.) in the presence of 85% potassium hydroxide (9.8 g.). The mixture was heated at reflux for 6 hours then poured into water. Neutralisation gave the 16 free base which, on dissolving in ethanol and treatment with hydrogen chloride, yielded the title compound. This (12.4 g.) had M.P. 2479 C. after crystallisation from a mixture of ethanol and ether.
EXAMPLE 5 1 1- [3 (p-cyclohexylphenyl -2-hydroxypropyl] -4- (p-nitrophenyl) piperazine hydrochloride The title compound was prepared by treating a solution of 1-chloro-3-(p-cyclohexylphenyl)propan-Z-ol (13.1 g.) in ethanol (120 ml.) with potassium hydroxide (4.0 g.) in methanol (25 ml.), below 10 C., followed by l-(p-nitrophenyl)piperazine. The mixture stood 6 days at room temperature. Isolation of the base and conversion into the hydrochloride, as described in Example 2, yielded the title compound (11.6 g.) which had a M.P. 156- 158 C., after crystallisation from a mixture of 1,2-dichloroethane and light petroleum (B.P. 6080 C.).
We claim:
1. A piperazine compound of the formula -ornon on onm wherein R is selected from the group consisting of cycloalkyl having from 5 to 7 carbon atoms and cycloalkoxy having from 5 to 7 carbon atoms,
R is selected from the group consisting of phenyl and phenyl substituted with a group selected from those consisting of alkyl having from 1 to 4 carbon atoms, alkoxy having from 1 to 4 carbon atoms, fluorine, chlorine, and trifluoromethyl; and their pharmaceutically acceptable acid addition salts.
2. A compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl] 4-o-tolylpiperazine hydrochloride.
3. A compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl]-4-m-tolylpiperazine hydrochloride.
4. A compound according to claim 1 consisting of l- (p chlorophenyl) 4 [3-(p-cyclohexylphenyl)-2-hydroxypropyl]-piperazine hydrochloride.
5. A compound according to claim 1 consisting of 1 o chlorophenyl 4 [3-(p-chlorhexylphenyl)-2-hydroxypropyl]-piperazine dihydrochloride.
6. A compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) Z-hydroxypropyl]-4-o-methoxyphenylpiperazine dihydrochloride.
7. A compound according to claim 1 consisting of 1-[3- (p cyclohexylphenyl) 2 hydroxypropyl]-4-(m-methoxyphenyl -piperazine dihydrochloride.
8. A compound according to claim 1 consisting of l- [3 (p cyclohexylphenyl)-2-hydroxypropyl]-4-phenylpiperazine dihydrochloride.
9. A compound according to claim 1 consisting of 1- [3 (p cyclohexyloxyphenyl)-2-hydroxypropyl]-4-(omethoxyphenyl -piperazine hydrochloride.
10. A compound according to claim 1 consisting of 1- [3 (p cyclohexylphenyl) 2-hydroxypropyl]-4-(o-fiuorophenyl)-piperazine hydrochloride.
11. A compound according to claim 1 consisting of l- [3 (p cyclohexylphenyl)-2-hydroxypropyl]-4-(p-fluorophenyl -piperazine hydrochloride.
12. A compound according to claim 1 consisting of 1- (m chlorophenyl) 4 [3 (p-cyclohexylphenyl)-2- hydroxypropyl]-piperazine hydrochloride.
13. A compound according to claim 1 consisting of 1- [3 (p cyclohexylphenyl) 2 hydroxypropy11-4-(oethoxyphenyl)-piperazine hydrochloride.
References Cited UNITED STATES PATENTS Pollard 260268 Heywood 260268 Janssen 260268 Janssen 260--268 Parcell 260268 Geschicter et a1. 260268 18 Shapiro 260268 Ash et a1. 260268 De Stevens 260268 PH Hansen 260268 PH Fauran 260268 G Umeomoto 260268 R DONALD G. DAUS, Primary Examiner US. Cl. X.R.
US00156092A 1967-07-05 1971-06-23 3-cyclohexyl phenyl-2-hydroxypropyl-4-phenyl piperazines Expired - Lifetime US3732229A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30873/67A GB1171251A (en) 1967-07-05 1967-07-05 Preparation of Piperazine Derivatives

Publications (1)

Publication Number Publication Date
US3732229A true US3732229A (en) 1973-05-08

Family

ID=10314465

Family Applications (1)

Application Number Title Priority Date Filing Date
US00156092A Expired - Lifetime US3732229A (en) 1967-07-05 1971-06-23 3-cyclohexyl phenyl-2-hydroxypropyl-4-phenyl piperazines

Country Status (13)

Country Link
US (1) US3732229A (en)
AT (1) AT281038B (en)
CH (1) CH496005A (en)
DE (1) DE1770805A1 (en)
DK (1) DK120998B (en)
ES (1) ES355739A1 (en)
FR (1) FR1583999A (en)
GB (1) GB1171251A (en)
IE (1) IE32152B1 (en)
IL (1) IL30313A (en)
NL (1) NL6809422A (en)
NO (1) NO126082B (en)
SE (1) SE352891B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947411A (en) * 1972-09-21 1976-03-30 Warner-Lambert Company Novel 1-aryl-2-arylalkyl-3-or-4-[4'-(substituted-alkyl)piperazino-1']butanols-2-or-butenes-1, and methods of manufacture thereof
US3951978A (en) * 1972-04-22 1976-04-20 Istituto Luso Farmaco D'italia S.R.L. 1,3-Disubstituted 3-aroylpropanes and process for the preparation thereof
US5430033A (en) * 1993-04-27 1995-07-04 John Wyeth & Brother Ltd. Piperazine derivatives
US20110144120A1 (en) * 2008-06-16 2011-06-16 Sanofi-Aventis Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081557B1 (en) * 1970-03-02 1973-08-10 Cerm Cent Europ Rech Mauvernay
AU2868601A (en) * 2000-01-27 2001-08-07 Ribotargets Ltd Biaryl compounds, their preparation and their use in therapy

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951978A (en) * 1972-04-22 1976-04-20 Istituto Luso Farmaco D'italia S.R.L. 1,3-Disubstituted 3-aroylpropanes and process for the preparation thereof
US3947411A (en) * 1972-09-21 1976-03-30 Warner-Lambert Company Novel 1-aryl-2-arylalkyl-3-or-4-[4'-(substituted-alkyl)piperazino-1']butanols-2-or-butenes-1, and methods of manufacture thereof
US5430033A (en) * 1993-04-27 1995-07-04 John Wyeth & Brother Ltd. Piperazine derivatives
US20110144120A1 (en) * 2008-06-16 2011-06-16 Sanofi-Aventis Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof
CN102123995A (en) * 2008-06-16 2011-07-13 赛诺菲-安万特 Phenyl-alkyl piperazines having a modulating activity of tnf
US8153637B2 (en) * 2008-06-16 2012-04-10 Sanofi Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof

Also Published As

Publication number Publication date
GB1171251A (en) 1969-11-19
DE1770805A1 (en) 1972-01-13
DK120998B (en) 1971-08-16
CH496005A (en) 1970-09-15
IE32152L (en) 1969-01-05
ES355739A1 (en) 1969-12-16
NO126082B (en) 1972-12-18
AT281038B (en) 1970-05-11
FR1583999A (en) 1969-12-12
SE352891B (en) 1973-01-15
IE32152B1 (en) 1973-05-02
NL6809422A (en) 1969-01-07
IL30313A (en) 1972-08-30
IL30313A0 (en) 1968-09-26

Similar Documents

Publication Publication Date Title
US3010965A (en) 1, 1, 2-tris-aryl-3-tertiary-amino-1-propenes, intermediates, and preparation thereof
US3701777A (en) Substituted (3-(4-phenyl-1-piperazinyl) propoxy or propyl thio) anilines
US3940386A (en) Substituted cinnamoyl-piperazine-pyridyl compound
US2454092A (en) Benzhydryl amino ethers
US3732229A (en) 3-cyclohexyl phenyl-2-hydroxypropyl-4-phenyl piperazines
US4129565A (en) Isocarbostyril derivatives
IL23338A (en) N-phenylpiperazine compounds
US3258488A (en) Dibenzo[a, d]cycloheptene derivatives
US4100285A (en) N-substituted trialkoxybenzyl piperazine derivatives
US3497508A (en) Alpha-(2-(morpholinomethyl)phenyl) benzyl alcohols
Lutz et al. Secondary and Tertiary Amino Ketones and Alcohols Derived from Desoxybenzoin and 1, 2-Diphenylethanol. 1 Ring-Chain Tautomerism of the α-(β-Hydroxyethylamino) Ketones2
US4478750A (en) 1-Phenyl-azepinoindoles
US3988456A (en) 1,2-Diphenylethanolamine derivatives and their salts and the preparation thereof
US2599001A (en) Nu, nu-disubstituted-beta-haloalkylamines
US3235598A (en) Aminoalkoxy-substituted-salicylaldehydes
US3167556A (en) Basic derivatives of anilides
US4079066A (en) 4-Naphthyl derivatives of 7-aminoalkylenoxy-2H-chromene
US4140790A (en) 3-(4-Substituted piperazino)-1-xanthene-9-carbonyloxy-propanes
US2751388A (en) Process for preparing benzhydryl ethers
US3822266A (en) (3-(1-piperazinyl)-2-hydroxy-propoxy)acetanilides
US2771469A (en) Quaternary ammonium salts of deltahydrocarbyoxyphenyl gamma-hydroxy amines
US3719679A (en) 9-(1-piperazinyl)-9,10-dihydro-9,10-et hanoanthracenes and their salts
US3668206A (en) Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols
US3929902A (en) 1-Phenyl-2, 3-butadien-1-ols
US3836534A (en) 5-piperazino-6-hydroxy-5h-benzo-cycloheptenes